StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)

Close on Nov 17, 2026Market cap $6.11MP/E –Yield –

Soligenix total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Soligenix's total debt was $162.49K at Sep 30, 2020.

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$162.49K–
Q2 FY2020Jun 30, 2020$232.13K–

More Soligenix figures

See a number that looks wrong?